Introduction
Stellate foveal retinoschisis is most commonly associated with congenital juvenile X-linked retinoschisis (CXLR) due to a defect in the RS1 gene. 1 CXLR typically affects young men and approximately half of them also develop peripheral retinoschisis. 1 Stellate nonhereditary idiopathic foveomacular retinoschisis (SNIFR) has been recently described as a new category of stellate foveal retinoschisis in which there is no evidence of hereditary or acquired predisposing condition. 2 Given its recent identification, the prevalence of this condition among patients with exudative maculopathies is unknown. We retrospectively analysed the spectral-domain optical coherence tomography (SD-OCT) findings acquired on 600 new patients attending a single tertiary referral centre between May 2012 and January 2014 for exudative maculopathies in Belfast, Northern Ireland. Fluorescein angiography (FA) and indocyanine green angiography (ICGA) were available, unless clinically contraindicated.
We identified two female patients who fit the definition of SNIFR. These patients presented with neovascular age-related macular degeneration (n-AMD) and underwent anti-VEGF treatment. We herein report on multimodal imaging findings and the clinical course of these two patients.
Case reports

Case 1
An 85 year-old woman was referred to our clinic for exudative maculopathy in the left eye (LE). Best-corrected visual acuity (BCVA) was 72 ETDRS letters in the right eye (RE) and 66 letters in the LE. Apart from well-controlled systemic hypertension, her medical history was unremarkable and family history was negative for any ocular disease. FA and ICGA showed an extrafoveal type 2 choroidal neovascularization (CNV) in the LE and scattered reticular pseudodrusen at the posterior pole of both eyes were visible on blue FAF (Figures 1 and 2 ). SD-OCT scans revealed intraretinal fluid (IRF) in the LE and also the presence of foveomacular retinoschisis in both eyes ( Figures 1 and 2) ; no peripheral retinoschisis was seen on the fundus examination of both eyes. The patient was treated with intravitreal injection of ranibizumab (0.5 mg per 0.05 ml) with a loading phase of monthly treatments over a 3-month period to the LE. One month after the third injection, BCVA slightly improved to 70 letters in the LE and was unchanged in the RE; SD-OCT scan showed resolution of IRF in the LE. However, the foveomacular retinoschisis remained unaltered ( Figure 1 ). Two years after the initiation of treatment, the OCT scans showed no recurrence of CNV activity and the vision in the LE was 69 letters (Figure 1) . No pathogenic mutations were detected within the coding sequence of RS1 gene. OCT scan in correspondence of the fovea shows subretinal fluid (SRF), a shallow PED, and a foveomacular retinoschisis with characteristic splitting of the OPL (arrows) at presentation (e); 3 months (g) and 12 months (i) after the initiation of anti-VEGF injections, SRF is no more detectable and retinoschisis is still evident. OCT scan passing above the fovea shows a more evident and extensive splitting of the OPL, which remained stable from the baseline (f), to 3 months (h), and to 12 months (j) after the treatment.
Case 2
An 81 year-old woman came to our attention for exudative maculopathy in the LE. BCVA was counter finger in RE and a disciform scar was found to be present in this eye. BCVA in the fellow eye was 66 letters. She had been a heavy smoker and she suffered from chronic obstructive pulmonary disease. Family history was negative for any ocular disease. FA and ICGA showed the presence of a type 1 CNV and concomitant presence of foveomacular retinoschisis, as revealed by SD-OCT scan (Figure 3) . Peripheral retinoschisis was absent on the fundus examination of both eyes. The patient underwent three monthly intravitreal injections of aflibercept (2.0 mg per 0.05 ml) to the LE. One month after the third injection, BCVA slightly improved to 70 letters in the LE. SD-OCT scan showed no signs of neovascular activity in the LE and the foveomacular retinoschisis seemed to be not affected by the intravitreal injections (Figure 3 ). Twelve months after the initiation of treatment, the OCT scans showed no recurrence of CNV activity and the vision in the LE was 71 letters.
Discussion
Recently Ober et al 2 described a series of patients with idiopathic retinoschisis. In this series, there was female predominance (16 females and one male) and only two patients presented bullous peripheral retinoschisis in addition to the typical foveomacular retinoschisis. Genetic testing for RS1 gene was performed in eight patients and revealed no known disease-causing mutations. All the patients demonstrated splitting of the outer plexiform layer (OPL) in the macula and the visual acuity was relatively preserved, except in a single patient in whom subretinal fluid developed under the fovea.
The aim of our study was to see whether this condition occurred in patients diagnosed as exudative maculopathy undergoing intravitreal injections. We excluded patients presenting with retinoschisis secondary to epiretinal membrane, vitreomacular traction, myopia, and other acquired predisposing conditions. On a total of 600 patients analysed, we found two patients (0.3%) with idiopathic retinoschisis with n-AMD. The patients were females and there was no family history of CXLR or other hereditary maculopathies. The absence of peripheral retinoschisis, the female gender, and the absence of mutation in RS1 gene in case 1 were in keeping with those reported by Ober et al 2 in their series.
The typical stellate foveomacular appearance at the macula of our patients was not present. We believe this was possibly due to the concomitant presence of AMD. However, in the RE of case 1, in which there was no exudative maculopathy, infra-red reflectance imaging barely showed the stellate appearance with radial spoking around the fovea.
As far as we know, this is the first report on the association of foveomacular retinoschisis with n-AMD. In our cases, intravitreal anti-VEGF injections were effective in that treatment resulted in resolution of the exudative maculopathy but the retinoschisis remained unaffected. In summary, SNIFR and exudative maculopathies can occur in the same eye. It is important to recognise the presence of foveal retinoschisis when concomitant to a neovascular complex, because retinoschisis can be misinterpreted as intraretinal fluid, possibly prompting unnecessary treatment.
Summary
What was known before K Stellate nonhereditary idiopathic foveomacular retinoschisis (SNIFR) is a new category of retinoschisis.
K In SNIFR, visual acuity is relatively preserved.
What this study adds K SNIFR may be concomitant to exudative maculopathies, such as neovascular age-related macular degeneration (n-AMD) in which vision may be compromised.
